It Is Getting Harder and Harder to be an Optimist

December 13, 2016 - Trish Vradenburg
Share:

The recent announcement by Eli Lilly that a new drug intended to slow memory loss in people with Alzheimer’s had failed a late-stage clinical trial felt like a punch in the gut. Look, I know that finding a treatment for dementia is a complex, Herculean task. But I was so sure that this time it was going to happen. And when it didn’t, I knew the devastation that the thousands of people who volunteered for this clinical trial must have felt, as well as the dedicated Eli Lilly researchers and all those who’d devoted their time and energy to crushing this relentless killer. (Continue reading on Huffington Post.)

About the Author

UsAgainstAlzheimer's

Trish Vradenburg

UsAgainstAlzheimer's is a 501(c)(3) organization connecting networks of organizations and individuals to take action to end Alzheimer’s by 2020, while providing the general public, policy leaders and the media with vital information about Alzheimer’s disease.